CVRdatabase
Menu

Zevra Denmark A/S

Public limited companyCVR 43259326FrederiksbergActive

Zevra Denmark A/S is a public limited company, based in Frederiksberg, active in research and experimental development on natural sciences and engineering, founded in 2022. After a loss in 2024, the company made a profit of DKK 334.5m in 2025. Measured by gross profit, it ranks no. 8 of 421 companies in the industry in the database. 8 other companies in the database are registered at the same address.

Follow
PDF reportCompare

Key figures · financial year 2025

RevenueDKK 123.3m+73.8% vs. 2024
Net profitDKK 334.5m+353.2% vs. 2024
EquityDKK 174.8m+209.5% vs. 2024
Employees4latest month from CVR

What has changed

calculated from recorded figures and dates

Financials: 2025 against 2024

  • Revenue rose 74% (2024 → 2025), to DKK 123.3m.
  • Net profit went from a loss of DKK 132.1m to a profit of DKK 334.5m (2024 → 2025).
  • Equity turned positive again: DKK 174.8m (2024 → 2025).

Management and owners, last 24 months

  • New in management: Rahsaan Waleed Thompson (chair of the board, 16/07/2025), Timothy Sangiovanni (ceo, 31/12/2025) and Timothy Sangiovanni (board member, 31/12/2025) (+1).
  • Stepped down: Raymond La Duane Clifton (ceo, 31/12/2025), Raymond La Duane Clifton (board member, 31/12/2025) and Neil McFarlane (chair of the board, 16/07/2025).

Registrations, last 24 months

  • 01/01/2025: Industry changed to Research and experimental development on natural sciences and engineering (721000)

Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.

Financial statements

Financial years 2022–2025 · amounts in DKK thousand

Equity and net profit

−DKK 200m−DKK 100mDKK 0DKK 100mDKK 200mDKK 300m2022202320242025
EquityNet profit
Financial figures for Zevra Denmark A/S
2022202320242025Change
Revenuenot statednot stated70,973123,335+73.8%
Gross profit1,671−12,548−1,728404,024+23,481%
Operating profit (EBIT)−12,009−28,188−29,053357,338+1,330%
Profit before tax−11,980−26,602−28,720353,622+1,331.3%
Net profit−7,406−20,506−132,114334,468+353.2%
Total assets199,206189,146178,169538,365+202.2%
Equity−7,006−27,513−159,627174,841+209.5%
Liabilities205,286216,329332,403359,475+8.1%
Cash and cash equivalents19,19924,45414,49319,753+36.3%
Average number of employees86440%

Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report. Revenue is not stated for 2022, 2023: smaller companies may omit it, and we do not derive it from other figures. Gross profit can exceed revenue when the company has other operating income or is a financial company.

Download the figures as CSV · free with an account, amounts in whole DKK

−DKK 100mDKK 0DKK 100mDKK 200mDKK 300mDKK 400m2022202320242025
Gross profitMedian, the industry (431 companies)

Annual reports

4 financial years
Annual reports for Zevra Denmark A/S
Financial yearPeriodPublishedFigures forDocuments
202501/01/2025 – 31/12/202508/07/2026The companyPDF not statedXBRL
202401/01/2024 – 31/12/202418/07/2025The companyPDFXBRL
202301/01/2023 – 31/12/202317/07/2024The companyPDFXBRL
202213/05/2022 – 31/12/202224/07/2023The companyPDF not statedXBRL

The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.

Employees

monthly figures from CVR
024681008/2309/2310/2311/2312/2301/2402/2403/2404/2405/2406/2407/2408/2409/2410/2411/2412/2401/2502/2503/2504/2505/2506/2507/2508/2509/2510/2511/2512/2501/2602/2603/2604/2605/2606/2607/26
Employees

Position in the industry

431 companies in the database

Comparison with the other companies in research and experimental development on natural sciences and engineering based on the latest financial year.

Gross profitDKK 404mNo. 8 of 421
Better than 98% of the companies in the industry
EquityDKK 174.8mNo. 24 of 431
Better than 95% of the companies in the industry
Number of employees4No. 224 of 431
Better than 48% of the companies in the industry

Industry median: gross profit DKK 616k, net profit −DKK 892k, equity DKK 2m, 5 employees.

DKK 100kDKK 2.5mDKK 63.4mDKK 1.6bnDKK 13.7bnHere
Distribution of gross profit for 250 companies in the industry (latest financial year, logarithmic scale). Amber bar: where this company sits.

Compared with similar companies

size, age and company form
Rank among similar companies
GroupGross profitEquity
Companies with fewer than 20 employees69,967 companies in the comparison
No. 91of 69,742
Better than 100%
No. 1,166of 69,964
Better than 98%
Same industry and fewer than 20 employees329 companies in the comparison
No. 1of 323
Better than 100%
No. 2of 329
Better than 100%
Companies that are founded within the last five years16,662 companies in the comparison
No. 17of 16,614
Better than 100%
No. 145of 16,661
Better than 99%
All companies of type A/S18,025 companies in the comparison
No. 369of 17,786
Better than 98%
No. 1,581of 18,024
Better than 91%

The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.

Compare with the industry

Research and experimental development on natural sciences and engineering
Gross profit
  1. Zevra Denmark A/SDKK 404m
  2. Carlsberg A/SDKK 40.2bn
  3. Zealand Pharma A/SDKK 9.2bn
Net profit
  1. Zevra Denmark A/SDKK 334.5m
  2. Carlsberg A/SDKK 7bn
  3. Zealand Pharma A/SDKK 6.5bn
Equity
  1. Zevra Denmark A/SDKK 174.8m
  2. Carlsberg A/SDKK 30.7bn
  3. Zealand Pharma A/SDKK 14.8bn
Employees
  1. Zevra Denmark A/S4
  2. Carlsberg A/S107
  3. Zealand Pharma A/S569

Latest financial year per company. Choose up to three companies from the largest in the industry.

Owners and group

from the Public Ownership Register
Owners
  • Zevra Therapeutics, Inc.100%
Zevra Denmark A/S

Management

5 active registrations

Executive management

Executive management at Zevra Denmark A/S
NameRoleAppointed
Timothy SangiovanniCEO31/12/2025

Board of directors

Board of directors at Zevra Denmark A/S
NameRoleAppointed
Thomas WeitemeyerBoard member13/05/2022
Rahsaan Waleed ThompsonChair of the board16/07/2025
Timothy SangiovanniBoard member31/12/2025
Justin Andrew RenzBoard member08/06/2026
Founders
Zevra Therapeutics, Inc.
Former management (4)
Former management at Zevra Denmark A/S
NameRoleAppointedResigned
Raymond La Duane CliftonCEO13/05/202231/12/2025
Raymond La Duane CliftonBoard member13/05/202231/12/2025
Travis Clark MickleChair of the board13/05/202225/03/2024
Neil McFarlaneChair of the board25/03/202416/07/2025

Signing rule: Selskabet tegnes af én direktør

Address and production units

1 active production units

Nordre Fasanvej 215
2000 Frederiksberg

Frederiksberg Municipality · Postcode 2000

Other companies at the address (8)

  • Sparrow Quantum ApSManufacture of computers and peripheral equipment
  • Adcendo ApSResearch and experimental development on natural sciences and engineering
  • Hemab ApSManufacture of pharmaceutical preparations
  • Orbis Medicines ApSResearch and experimental development on natural sciences and engineering
  • Minervax ApSResearch and experimental development on natural sciences and engineering
Production units
Production unitAddressEmployeesP number
Zevra Denmark A/SNordre Fasanvej 215, 2000 Frederiksberg31028248853

Purpose

Selskabets formål er forskning, udvikling, produktion, markedsføring, salg og/eller licensudstedelse af medicinske produkter til behandling af forskellige sygdomme samt hermed beslægtede aktiviteter efter bestyrelsens skøn.

The purpose is quoted from the register in Danish.

Changes year by year

23 registered events
20262 changesaccounts 1 · management 1
  • Annual report for 2025 published
  • Justin Andrew Renz appointed board member
20258 changesmanagement 6 · accounts 1 · industry 1
  • Timothy Sangiovanni appointed ceo
  • Timothy Sangiovanni appointed board member
  • Raymond La Duane Clifton stepped down as board member
  • Raymond La Duane Clifton stepped down as ceo
  • Annual report for 2024 published
  • Rahsaan Waleed Thompson appointed chair of the board
  • Neil McFarlane stepped down as chair of the board
  • Industry changed to Research and experimental development on natural sciences and engineering (721000)
20244 changesaccounts 1 · address 1 · management 2
  • Annual report for 2023 published
  • Moved to Nordre Fasanvej 215, 2000 Frederiksberg
  • Neil McFarlane appointed chair of the board
  • Travis Clark Mickle stepped down as chair of the board
20232 changesaccounts 1 · name 1
  • Annual report for 2022 published
  • Name changed from KemPharm Denmark A/S to Zevra Denmark A/S
20227 changesaddress 1 · founded 1 · management 4 · ownership 1
  • Moved to Ole Maaløes Vej 3, 2200 København N
  • Registered as KemPharm Denmark A/S
  • Thomas Weitemeyer appointed board member
  • Raymond La Duane Clifton appointed board member
  • Travis Clark Mickle appointed chair of the board
  • Raymond La Duane Clifton appointed ceo
  • Zevra Therapeutics, Inc. registered as owner (100%)

Related companies

Same industry in Frederiksberg

See all →

Same people in management

Largest in the industry

See all →

Source and updates

The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 24/10/2026. The company is protected against advertising; contact details are not shown, and the data must not be used for marketing.

View in CVRReport a correction